Tezepelumab Increases Probability Of SNOT-22 Low Disease Severity Scores Among Patients With CRSwNP (WAYPOINT) Meeting Abstract

publication date

  • February 1, 2026

webpage

published in

volume

  • 157

issue

  • 2